Screener
Medtronic MDT Non-Controlling Interests
Non-Controlling Interests at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:MinorityInterest.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions, except share amounts) | April 24, 2026 | April 25, 2025 |
|---|---|---|
| Ordinary shares— par value $0.0001, 2.6 billion shares authorized, 1,280,177,293 and 1,281,934,628 shares issued and outstanding, respectively | — | — |
| Additional paid-in capital | 20,926 | 20,833 |
| Retained earnings | 32,638 | 31,476 |
| Accumulated other comprehensive loss | (4,101) | (4,284) |
| Total shareholders’ equity | 49,463 | 48,024 |
| Noncontrolling interests | 609 | 232 |
| Total equity | 50,072 | 48,256 |
| Total liabilities and equity | $93,028 | $91,680 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's non-controlling interests?
- Medtronic (MDT) reported non-controlling interests of $609M in Q1 2026.
- How has Medtronic's non-controlling interests changed year-over-year?
- Medtronic's non-controlling interests increased by 162.5% year-over-year, from $232M to $609M.
- What is the long-term trend for Medtronic's non-controlling interests?
- Over 5 years (2021 to 2026), Medtronic's non-controlling interests has grown at a 28.5% compound annual growth rate (CAGR), from $174M to $609M.
- What does non-controlling interests mean?
- Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.
Ask your AI about Medtronic's non-controlling interests.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude